Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,0196 EUR | -3,92% | -20,00% | -67,97% |
11/04 | BioSenic dient herstructureringsplan in | AM |
20/03 | BioSenic presenteert succesvolle studiedata op het Systemic Sclerosis World Congress 2024 | AM |
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 3,6 mln. 3,83 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -5 mln. -5,33 mln. | Nettowinst (verlies) 2024 * | -11 mln. -11,72 mln. | EV/omzet 2023 * | - |
Nettoschuld 2023 * | 18,8 mln. 20,03 mln. | Nettoschuld 2024 * | 29,3 mln. 31,21 mln. | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,39
x | K/w-verhouding 2024 * |
-0,22
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 73,38% |
1 dag | -3,92% | ||
1 week | -20,00% | ||
Lopende maand | -10,91% | ||
1 maand | -14,78% | ||
3 maanden | -58,30% | ||
6 maanden | -69,38% | ||
Lopend jaar | -67,97% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Francois Rieger
CEO | Chief Executive Officer | - | - |
Lieven Huysse
CTO | Chief Tech/Sci/R&D Officer | - | 03-04-23 |
Nicco Carole
COO | Chief Operating Officer | - | 18-01-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | - | |
Director/Board Member | 53 | - | |
Francois Rieger
CEO | Chief Executive Officer | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 0,0196 | -3,92% | 1 916 470 |
18-04-24 | 0,0204 | +0,99% | 2 324 980 |
17-04-24 | 0,0202 | -5,61% | 2 170 959 |
16-04-24 | 0,0214 | -3,60% | 790 605 |
15-04-24 | 0,0222 | -3,90% | 1 187 489 |
Real Time Euronext Bruxelles, 19 april 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-67,97% | 3,99 mln. | |
+24,60% | 672 mld. | |
+24,08% | 550 mld. | |
-5,63% | 351 mld. | |
+15,37% | 317 mld. | |
+7,38% | 292 mld. | |
+3,26% | 211 mld. | |
+0,78% | 203 mld. | |
-9,69% | 144 mld. | |
-6,63% | 141 mld. |